Bms-863233
In Stock•Starting at $103 for 10 mg•Purity ≥ 99%
| CAS No. | 1169558-38-6 |
|---|---|
| MDL No. | MFCD28137679 |
| MF | C14H12ClN3O2 |
| MW | 289.71 |
| InChI Key | JJWLXRKVUJDJKG-VIFPVBQESA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 10 mg | 99% | $103 | In Stock | |
| 25 mg | 99% | $192 | In Stock | |
| 50 mg | 99% | $324 | In Stock | |
| 100 mg | 99% | $549 | In Stock | |
| 250 mg | 99% | $1040 | In Stock |
Product Information
XL413 is a benzofuropyrimidine, specifically 3,4-dihydro[1]benzofuro[3,2-d]pyrimidine, substituted with (2S)-pyrrolidin-2-yl at position 2, an oxo group at position 4, and a chloro group at position 8. It is a potent ATP-competitive inhibitor of Cdc7 kinase (IC50 = 3.4 nM) with anticancer activity. It functions as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor and an antineoplastic agent. It is also an organochlorine compound and a member of the pyrrolidine class.
| CAS No. | 1169558-38-6 |
|---|---|
| Product Name | Bms-863233 |
| Heavy Atom Count | 20 | Rotatable Bond Count | 1 |
| Atom Stereo Count | 1 | Bond Stereo Count | 0 |
| HBA | 4 | HBD | 2 |
| TPSA | 70.920 Ų | Charge | 0 |
| Exact Mass | 289.06180 | Complexity | 861.85 |
| pKa | 5.875 | XLogP | 2.747 |